Form 4: Dentsply Sirona Executive Acquires and Disposes of Shares Through Dividend Reinvestment and Phantom Stock
SEC Form 4 Filing
Richard C. Rosenzweig, EVP at Dentsply Sirona, reports acquiring shares through dividend reinvestment and phantom stock accrual, while also disposing of shares.
Summary
- Richard C. Rosenzweig, an executive at Dentsply Sirona Inc., filed a Form 4 detailing changes in beneficial ownership.
- On October 11, 2024, Rosenzweig acquired 266.906 shares of common stock through dividend reinvestment at $0 per share.
- Rosenzweig also acquired 12.8646 shares of phantom stock due to accrued dividends within the Supplemental Executive Retirement Plan (SERP).
- The filing indicates Rosenzweig directly owns 56,207.949 shares of common stock following the reported transactions.
- Rosenzweig also holds 1,982.5335 shares of phantom stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The filing is a routine disclosure of executive stock transactions, with no explicit positive or negative implications for the company's performance.
Positives
- The acquisition of shares through dividend reinvestment indicates a continued investment in the company's stock.
Future Outlook
The document does not contain specific forward-looking statements, but the executive's continued holding of shares and participation in dividend reinvestment suggest a positive outlook.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. This filing indicates standard compensation practices, including dividend reinvestment and phantom stock awards, which are common in executive compensation packages.
Comparison to Industry Standards
- Dividend reinvestment programs are a common practice among publicly traded companies, allowing shareholders to automatically reinvest their dividends into additional shares.
- Phantom stock plans are also a fairly standard component of executive compensation, designed to align executive interests with shareholder value by providing benefits tied to the company's stock performance.
- Companies like Johnson & Johnson (JNJ) and Medtronic (MDT) also utilize similar compensation strategies to incentivize their executives.
Stakeholder Impact
- The filing provides transparency to shareholders regarding executive compensation and ownership.
Key Dates
| Date | Description |
|---|---|
| 10/11/2024 | Date of transaction for common stock and phantom stock acquisition. |
| 10/15/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.